3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Lung Neoplasms
3
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
7
Ipilimumab
5
Nivolumab
4
fludarabine
3
Radiosurgery
3
Drug Therapy
3
Cyclophosphamide
3
spartalizumab
2
aldesleukin
2
Sirolimus
2
Riluzole
2
Radiotherapy
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Oncolytic Virotherapy
2
Counseling
2
Bupropion
2
Blood Specimen Collection
2
vofatamab
1
utomilumab
1
trastuzumab deruxtecan
1
toripalimab
1
tocilizumab
1
sargramostim
1
saracatinib
1
pertuzumab
1
pazopanib
1
liposomal doxorubicin
1
ixabepilone
1
fostamatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Radionuclide Imaging
×
Thoracic
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled